Antibody-mediated immunity against lung cancer goes retro

Sci Immunol. 2023 Jun 8;8(84):eadi8769. doi: 10.1126/sciimmunol.adi8769. Epub 2023 Jun 2.

Authors

Stephanie N Langel¹, David R Martinez²

Affiliations

¹ Department of Pathology, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
² Department of Immunobiology, Yale Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.

PMID: 37276436
DOI: 10.1126/sciimmunol.adi8769

Abstract

Endogenous retrovirus antibody responses contribute to survival after immune checkpoint blockade therapy against lung adenocarcinoma.

Publication types

Comment

MeSH terms

Antibodies
Humans
Lung Neoplasms*
Programmed Cell Death 1 Receptor*

Substances

Programmed Cell Death 1 Receptor
Antibodies